Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures. It also holds an intellectual property portfolio that comprises 9 patent families, which include 9 patents granted in the United States, 12 patents granted outside the United States, and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Industry, Sector and Symbol
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Phone781-875-3605
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees7
Next Earnings Date2/27/2019 (Estimated)
OptionableNot Optionable
Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions
What is Microbot Medical's stock symbol?
Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."
When did Microbot Medical's stock split? How did Microbot Medical's stock split work?
Microbot Medical's stock reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split.
How were Microbot Medical's earnings last quarter?
Microbot Medical Inc (NASDAQ:MBOT) posted its quarterly earnings data on Wednesday, November, 14th. The biotechnology company reported ($0.58) EPS for the quarter, beating analysts' consensus estimates of ($0.60) by $0.02. View Microbot Medical's Earnings History.
When is Microbot Medical's next earnings date?
What price target have analysts set for MBOT?
1 analysts have issued 1 year price targets for Microbot Medical's shares. Their predictions range from $1.75 to $1.75. On average, they expect Microbot Medical's share price to reach $1.75 in the next year. This suggests that the stock has a possible downside of 80.8%. View Analyst Price Targets for Microbot Medical.
What is the consensus analysts' recommendation for Microbot Medical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Microbot Medical.
Has Microbot Medical been receiving favorable news coverage?
Media headlines about MBOT stock have been trending somewhat negative this week, InfoTrie reports. The research group rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Microbot Medical earned a daily sentiment score of -1.9 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an impact on the stock's share price in the near future.
Who are some of Microbot Medical's key competitors?
Some companies that are related to Microbot Medical include La Jolla Pharmaceutical (LJPC), Erytech Pharma (ERYP), Jounce Therapeutics (JNCE), Fennec Pharmaceuticals (FENC), Allena Pharmaceuticals (ALNA), Organovo (ONVO), Neon Therapeutics (NTGN), Surface Oncology (SURF), Pluristem Therapeutics (PSTI), Outlook Therapeutics (OTLK), Champions Oncology (CSBR), Nantkwest (NK), Idera Pharmaceuticals (IDRA), Brainstorm Cell Therapeutics (BCLI) and INmune Bio (INMB).
What other stocks do shareholders of Microbot Medical own?
Who are Microbot Medical's key executives?
Microbot Medical's management team includes the folowing people:
- Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 46)
- Prof. Moshe Shoham, Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 67)
- Mr. Yoseph Bornstein, Co-Founder & Director (Age 60)
- Mr. David Ben Naim CPA, M.B.A., Chief Financial Officer (Age 50)
- Mr. Yehezkel Himelfarb, COO, GM of Israeli operations & Director (Age 61)
Who are Microbot Medical's major shareholders?
Microbot Medical's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (0.51%). Company insiders that own Microbot Medical stock include Alliance Investment Management, Leon Lewkowicz, Moshe Shoham, Yoav Zvi Waizer and Yoseph Bornstein. View Institutional Ownership Trends for Microbot Medical.
Which institutional investors are buying Microbot Medical stock?
MBOT stock was bought by a variety of institutional investors in the last quarter, including Geode Capital Management LLC. Company insiders that have bought Microbot Medical stock in the last two years include Alliance Investment Management and Yoav Zvi Waizer. View Insider Buying and Selling for Microbot Medical.
How do I buy shares of Microbot Medical?
Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Microbot Medical's stock price today?
One share of MBOT stock can currently be purchased for approximately $9.11.
How big of a company is Microbot Medical?
Microbot Medical has a market capitalization of $39.26 million. Microbot Medical employs 7 workers across the globe.
What is Microbot Medical's official website?
How can I contact Microbot Medical?
Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected]
MarketBeat Community Rating for Microbot Medical (NASDAQ MBOT)
MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote "Outperform" if you believe MBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days.
